Rheumatology Clinical Trials in Myrtle Beach, SC
As of June 2026, 3 paid clinical trials are recruiting for Rheumatology in Myrtle Beach, South Carolina. Rheumatology trials test new biologics, JAK inhibitors, and immune-modulating agents for rheumatoid arthritis, psoriatic arthritis, lupus, and other systemic autoimmune diseases. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
3 clinical trials for Rheumatology
·Clear filters·↓ Download CSVBrivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa
Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa (TRuE-HS1)
About research studies in Myrtle Beach
Myrtle Beach has approximately 79 recruiting research studies across a wide range of therapeutic areas. South Carolina hosts a diverse network of universities, academic medical centers, and community hospitals that run clinical trials across oncology, cardiology, neurology, and many other therapeutic areas.
Top Research Study Locations in Myrtle Beach
Researchers run research studies in Myrtle Beach, SC at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Carolina Urologic Research Center | Prostate Cancer, Non-Muscle Invasive Bladder Neoplasms, Metastatic Castration-Resistant Prostate Cancer | 34 |
| Carolina Urologic Research Center, LLC | Prostate Cancer, Advanced Renal Cell Carcinoma, Advanced Renal Cell Carcinoma (RCC) | 12 |
| Parkway Surgery Center | Advanced Renal Cell Carcinoma, Advanced or Metastatic Renal Cell Carcinoma, Cancer of the Prostate | 6 |
| Grand Strand Medical Center | Acute Lower Limb Arterial Occlusion, Advanced Renal Cell Carcinoma, Advanced or Metastatic Renal Cell Carcinoma | 5 |
| Carolina Regional Cancer Center | Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma, Oligometastatic Prostate Cancer (OMPC) | 3 |
| AUC Urologists, LLC | Metastatic Castration-Resistant Prostate Cancer, Non-muscle Invasive Bladder Cancer | 2 |
| Trial Management Associates | Clostridioides Difficile Associated Disease, Obesity or Overweight | 2 |
| AMR Clinical South Strand, South Carolina | Hidradenitis Suppurativa | 1 |
| Atlantic Urology Specialists | Prostate Adenocarcinoma | 1 |
| Avenzo Therapeutics Recruiting Site | Locally Advanced, Metastatic Solid Tumors, Solid Tumor Cancer | 1 |
| Call for Information | Metastatic Castration-Resistant Prostate Cancer | 1 |
| Carolina Urologic Research Center, the START Center for Cancer Research | Metastatic Castration-Resistant Prostate Cancer Patients, Metastatic Castration-resistant Prostate Cancer, Metastatic Castration-resistant Prostate Cancer, mCRPC | 1 |
| Coastal Eye Group | Non-muscle Invasive Bladder Cancer | 1 |
| Exelixis Clinical | Clear Cell Renal Cell Carcinoma (ccRCC), Colorectal Cancer (CRC), Head and Neck Squamous Cell Carcinoma (HNSCC) | 1 |
| GSK Investigational Site | Neoplasms | 1 |
| HCA Grand Strand | Atrial Fibrillation, Stroke | 1 |
| Investigative | Hidradenitis Suppurativa | 1 |
| Kailera Clinical Site | Obesity | 1 |
| NEO-811 South Carolina Site | Clear Cell Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma Metastatic, Kidney Cancer Metastatic | 1 |
| OrthoSC | Degenerative Disc Disease | 1 |
| START Carolinas | Prostate Cancer (Adenocarcinoma), Prostate Cancer Patients Treated by Radiotherapy | 1 |
| Site 02-006 - Carolina Urologic Research Center | Non-Muscle Invasive Bladder Cancer ("NMIBC") Unresponsive/Intolerant to BCG | 1 |
| TMA Headlands LLC (d/b/a Trial Management Associates) | Body Weight, Nutrition Disorders, Nutritional and Metabolic Diseases | 1 |
| TMA Headlands LLC | Hypothyroidism | 1 |
| Teva Investigational | Asthma | 1 |
Active & Upcoming Studies in Myrtle Beach (2026)
Recruiting trials in Myrtle Beach grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (55 active studies)
- AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01) · Phase 3 · AstraZeneca
- A Study of GEN1106 in Participants With Solid Tumors · Phase 1 · Genmab
Diabetes & metabolic (3 active studies)
Neurology & pain (1 active study)
- The CONFORM Pivotal Trial · Conformal Medical, Inc
Cardiovascular (1 active study)
- The CONFORM Pivotal Trial · Conformal Medical, Inc
Common conditions studied in Myrtle Beach
- Prostate Cancer (12 active studies). Prostate cancer studies test next-generation hormone therapies, PARP inhibitors, and radioligand treatments for both localized and advanced disease.
- Metastatic Castration-Resistant Prostate Cancer (5 active studies). Prostate cancer studies test next-generation hormone therapies, PARP inhibitors, and radioligand treatments for both localized and advanced disease.
- Metastatic Castration-resistant Prostate Cancer (4 active studies). Prostate cancer studies test next-generation hormone therapies, PARP inhibitors, and radioligand treatments for both localized and advanced disease.
- Non-Muscle Invasive Bladder Neoplasms (4 active studies). Recruiting Non-Muscle Invasive Bladder Neoplasms studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Prostate Cancer (Adenocarcinoma) (4 active studies). Prostate cancer studies test next-generation hormone therapies, PARP inhibitors, and radioligand treatments for both localized and advanced disease.
- Bladder Cancer (2 active studies). Recruiting Bladder Cancer studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
Leading research sponsors in Myrtle Beach
- AstraZeneca
- Pfizer
- Janssen Research & Development, LLC
- Novartis Pharmaceuticals
- Astellas Pharma Global Development, Inc.
Local regulations and guidelines
Clinical trials in South Carolina are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. South Carolina research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Myrtle Beach. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Myrtle Beach
Hipa.ai aggregates every recruiting study in Myrtle Beach from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Myrtle Beach?
There are approximately 79 recruiting clinical trials in Myrtle Beach, South Carolina listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Myrtle Beach pay participants?
Most recruiting trials in Myrtle Beach compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Myrtle Beach?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Myrtle Beach?
The most common conditions under active study in Myrtle Beach include Prostate Cancer (12), Metastatic Castration-Resistant Prostate Cancer (5), Metastatic Castration-resistant Prostate Cancer (4), Non-Muscle Invasive Bladder Neoplasms (4), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Myrtle Beach?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Myrtle Beach on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Myrtle Beach?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Myrtle Beach?
Recruiting research sites in Myrtle Beach include Carolina Urologic Research Center, Carolina Urologic Research Center, LLC, Parkway Surgery Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Myrtle Beach right now?
The largest active categories in Myrtle Beach are Cancer & tumors (55), Diabetes & metabolic (3), Neurology & pain (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.